Utrecht Holdings the Knowledge Transfer Office (KTO) of Utrecht University and University Medical Center Utrecht, announced today the appointment of Tessa Scharringhausen as Director Knowledge Transfer. Tessa will start September first.
Oscar Schoots, CEO Utrecht Holdings, “We are delighted that Tessa joins our executive management team. Together we will work on further professionalizing the knowledge transfer organization. Her broad corporate experience is a valuable addition to our team.”
Tessa Scharringhausen is an experienced executive who joins Utrecht Holdings from Amgen Europe where she was Director External affairs & Payer innovation as of 2018. At Amgen Europe she set up the strategic plan and developed capabilities to engage on novel pricing and payment methodologies across the European region. From 2016-2018 she was Commercial Director at Amgen BV, where she lead the commercial team, accelerated commercial strategies, introduced customer centric planning, led the Innovation agenda and prepared new product launches.
Tessa studied Biopharmaceutical Sciences at the University of Leiden.
“I look forward to working with the Utrecht Holdings team and its stakeholders, focusing on the shared interests, achieving results together and bringing science to the market”, Tessa Scharringhausen,
Director Knowledge Transfer Utrecht Holdings.